The Management of Refractory Generalised Convulsive and Complex Partial Status Epilepticus in Three European Countries: a Survey Among Epileptologists and Critical Care Neurologists

Overview

Journal J Neurol Neurosurg Psychiatry

Publisher BMJ Publishing Group

Specialties Neurology
Neurosurgery
Psychiatry

Date 2003 Jul 24

PMID 12876241

Citations 21

Authors

M Holtkamp

F Masuhr

L Harms

K M Einhaupl

H Meierkord

K Buchheim

Affiliations

Soon will be listed here.

Abstract

Objective: To survey the current clinical treatment of refractory status epilepticus and to identify steps in its management which may need further investigation.

Methods: Epileptologists and critical care neurologists were surveyed using a standardised postal questionnaire.

Results: Sixty three of 91 participants (69%) returned the questionnaires. Two thirds of the respondents applied another non-anaesthetising anticonvulsant after failure of first line drugs. General anaesthesia for ongoing complex partial status epilepticus (CPSE) was part of the therapeutic regimen of 75% of the interviewees. A non-barbiturate as general anaesthetic of first choice was used by 42%. Up to 70% titrated the anaesthetic to achieve a burst suppression pattern in the electroencephalogram, indicating deep sedation, and 94% reduce anaesthesia within 48 hours.

Conclusions: The management of refractory status epilepticus is heterogeneous in many aspects, even among clinicians who are most familiar with this severe condition. Randomised trials are needed to compare the efficacy, side effects, optimal duration, and depth of general anaesthesia.

Citing Articles

Sustained effort network for treatment of status epilepticus/European academy of neurology registry on adult refractory status epilepticus (SENSE-II/AROUSE).

Damien C, Leitinger M, Kellinghaus C, Strzelczyk A, De Stefano P, Beier C BMC Neurol. 2024; 24(1):19.

PMID: 38178048 PMC: 10765797. DOI: 10.1186/s12883-023-03505-y.

The Origin of the Burst-Suppression Paradigm in Treatment of Status Epilepticus.

Hawkes M, Eliliwi M, Wijdicks E Neurocrit Care. 2023; 40(3):849-854.

PMID: 37921932 DOI: 10.1007/s12028-023-01877-0.

Association Between Induced Burst Suppression and Clinical Outcomes in Patients With Refractory Status Epilepticus: A 9-Year Cohort Study.

Fisch U, Junger A, Baumann S, Semmlack S, De Marchis G, Hunziker S Neurology. 2023; 100(19):e1955-e1966.

PMID: 36889924 PMC: 10186226. DOI: 10.1212/WNL.0000000000207129.

Electrographic predictors of successful weaning from anaesthetics in refractory status epilepticus.

Rubin D, Angelini B, Shoukat M, Chu C, Zafar S, Westover M Brain. 2020; 143(4):1143-1157.

PMID: 32268366 PMC: 7174057. DOI: 10.1093/brain/awaa069.

Refractory and Super-refractory Status Epilepticus.

Samanta D, Garrity L, Arya R Indian Pediatr. 2020; 57(3):239-253.

PMID: 32198865 PMC: 7224023.

References

Borbas C, Morris N, McLaughlin B, Asinger R, Gobel F . The role of clinical opinion leaders in guideline implementation and quality improvement. Chest. 2000; 118(2 Suppl):24S-32S. DOI: 10.1378/chest.118.2_suppl.24s. View

Kaplan P . Assessing the outcomes in patients with nonconvulsive status epilepticus: nonconvulsive status epilepticus is underdiagnosed, potentially overtreated, and confounded by comorbidity. J Clin Neurophysiol. 1999; 16(4):341-52; discussion 353. DOI: 10.1097/00004691-199907000-00006. View

Holtkamp M, Tong X, Walker M . Propofol in subanesthetic doses terminates status epilepticus in a rodent model. Ann Neurol. 2001; 49(2):260-3. View

Knake S, Rosenow F, Vescovi M, Oertel W, Mueller H, Wirbatz A . Incidence of status epilepticus in adults in Germany: a prospective, population-based study. Epilepsia. 2001; 42(6):714-8. DOI: 10.1046/j.1528-1157.2001.01101.x. View

Claassen J, Hirsch L, Emerson R, Bates J, Thompson T, Mayer S . Continuous EEG monitoring and midazolam infusion for refractory nonconvulsive status epilepticus. Neurology. 2001; 57(6):1036-42. DOI: 10.1212/wnl.57.6.1036. View

Mayer S, Claassen J, Lokin J, Mendelsohn F, Dennis L, Fitzsimmons B . Refractory status epilepticus: frequency, risk factors, and impact on outcome. Arch Neurol. 2002; 59(2):205-10. DOI: 10.1001/archneur.59.2.205. View

Claassen J, Hirsch L, Emerson R, Mayer S . Treatment of refractory status epilepticus with pentobarbital, propofol, or midazolam: a systematic review. Epilepsia. 2002; 43(2):146-53. DOI: 10.1046/j.1528-1157.2002.28501.x. View

Meldrum B, BRIERLEY J . Prolonged epileptic seizures in primates. Ischemic cell change and its relation to ictal physiological events. Arch Neurol. 1973; 28(1):10-7. DOI: 10.1001/archneur.1973.00490190028002. View

Meldrum B, Horton R . Physiology of status epilepticus in primates. Arch Neurol. 1973; 28(1):1-9. DOI: 10.1001/archneur.1973.00490190019001. View

10.

Engel Jr J, Ludwig B, Fetell M . Prolonged partial complex status epilepticus: EEG and behavioral observations. Neurology. 1978; 28(9 Pt 1):863-9. DOI: 10.1212/wnl.28.9.863. View

11.

Aminoff M, Simon R . Status epilepticus. Causes, clinical features and consequences in 98 patients. Am J Med. 1980; 69(5):657-66. DOI: 10.1016/0002-9343(80)90415-5. View

12.

Rashkin M, Youngs C, Penovich P . Pentobarbital treatment of refractory status epilepticus. Neurology. 1987; 37(3):500-3. DOI: 10.1212/wnl.37.3.500. View

13.

Lowenstein D, Aminoff M, Simon R . Barbiturate anesthesia in the treatment of status epilepticus: clinical experience with 14 patients. Neurology. 1988; 38(3):395-400. DOI: 10.1212/wnl.38.3.395. View

14.

Shorvon S . Tonic clonic status epilepticus. J Neurol Neurosurg Psychiatry. 1993; 56(2):125-34. PMC: 1014809. DOI: 10.1136/jnnp.56.2.125. View

15.

Wasterlain C, Fujikawa D, Penix L, Sankar R . Pathophysiological mechanisms of brain damage from status epilepticus. Epilepsia. 1993; 34 Suppl 1:S37-53. DOI: 10.1111/j.1528-1157.1993.tb05905.x. View

16.

Walker M, Smith S, Shorvon S . The intensive care treatment of convulsive status epilepticus in the UK. Results of a national survey and recommendations. Anaesthesia. 1995; 50(2):130-5. DOI: 10.1111/j.1365-2044.1995.tb15095.x. View

17.

Krumholz A, Sung G, Fisher R, Barry E, Bergey G, Grattan L . Complex partial status epilepticus accompanied by serious morbidity and mortality. Neurology. 1995; 45(8):1499-504. DOI: 10.1212/wnl.45.8.1499. View

18.

DeLorenzo R, Hauser W, Towne A, Boggs J, Pellock J, Penberthy L . A prospective, population-based epidemiologic study of status epilepticus in Richmond, Virginia. Neurology. 1996; 46(4):1029-35. DOI: 10.1212/wnl.46.4.1029. View

19.

Krishnamurthy K, Drislane F . Relapse and survival after barbiturate anesthetic treatment of refractory status epilepticus. Epilepsia. 1996; 37(9):863-7. DOI: 10.1111/j.1528-1157.1996.tb00039.x. View

20.

Aminoff M . Do nonconvulsive seizures damage the brain?--No. Arch Neurol. 1998; 55(1):119-20. DOI: 10.1001/archneur.55.1.119. View